Aparna Deora is the Vice-President of BTx Portfolio and Strategy at Pfizer, where they are currently progressing the vaccine portfolio. Previously, Aparna served as a Scientist at Pharmacia, focusing on COX2 inhibitors in anti-cancer therapies, and held various leadership roles at Pfizer, including Group Leader in bioassay development. Aparna completed a Ph.D. in Molecular Genetics at Washington University in St. Louis and holds a B.Sc. in Chemistry and Cellular and Molecular Biology from the University of Michigan. Additionally, they worked as a Postdoctoral Fellow at Washington University School of Medicine, employing advanced techniques in molecular biology and protein analysis.
This person is not in the org chart
This person is not in any teams
This person is not in any offices